Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Henry Boom

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 23, 2009
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversionJohn L Johnson, David Jamil Hadad, Reynaldo Dietze, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
JCI Insight|May 8, 2024
MR1-restricted T cell clonotypes are associated with "resistance" to Mycobacterium tuberculosis infectionDeborah L Cross, Erik D Layton, Krystle Kq Yu, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Distinct antibody-based signatures and functionality distinguish latent and active pediatric tuberculosisNadege Nziza, Wonyeong Jung, Tina Chen, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2019
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by MycobacteriaSara Suliman, Melissa Murphy, Munyaradzi Musvosvi, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 2011
CD8+ T cells provide an immunologic signature of tuberculosis in young childrenChristina Lancioni, Melissa Nyendak, Sarah Kiguli, et al.
Mbio|January 25, 2022
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam ActionKhalid M Dousa, David C Nguyen, Sebastian G Kurz, et al.
Frontiers in Immunology|May 1, 2018
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household ContactsFergal J Duffy, Ethan Thompson, Katrina Downing, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Human genetic variation associates with infection by derived Ugandan M. tuberculosis lineageCatherine M Stein, Penelope Benchek, Lentlamatse Mantshoyane, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
American Journal of Respiratory and Critical Care Medicine|June 23, 2009
Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversionJohn L Johnson, David Jamil Hadad, Reynaldo Dietze, et al.
The New England Journal of Medicine|August 30, 2018
Bacterial Factors That Predict Relapse after Tuberculosis TherapyRoberto Colangeli, Hannah Jedrey, Soyeon Kim, et al.
JCI Insight|May 8, 2024
MR1-restricted T cell clonotypes are associated with "resistance" to Mycobacterium tuberculosis infectionDeborah L Cross, Erik D Layton, Krystle Kq Yu, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Distinct antibody-based signatures and functionality distinguish latent and active pediatric tuberculosisNadege Nziza, Wonyeong Jung, Tina Chen, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2019
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by MycobacteriaSara Suliman, Melissa Murphy, Munyaradzi Musvosvi, et al.
American Journal of Respiratory and Critical Care Medicine|November 11, 2011
CD8+ T cells provide an immunologic signature of tuberculosis in young childrenChristina Lancioni, Melissa Nyendak, Sarah Kiguli, et al.
Mbio|January 25, 2022
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam ActionKhalid M Dousa, David C Nguyen, Sebastian G Kurz, et al.
Frontiers in Immunology|May 1, 2018
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household ContactsFergal J Duffy, Ethan Thompson, Katrina Downing, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Human genetic variation associates with infection by derived Ugandan M. tuberculosis lineageCatherine M Stein, Penelope Benchek, Lentlamatse Mantshoyane, et al.
Pageof 19